LANZHOU FOCI PHARMACEUTICAL CO.,LTD.

Lanzhou Foci Pharmaceutical Co.,Ltd is holding subsidiary of Foci Pharmaceutical Group, the registered capital is 511 million yuan. Foci went to public on the Shenzhen Stock Exchange in 2011 and is the only state-holding listed company of Lanzhou. Foci Pharmaceutical moved to Lanzhou New Area in September 2018. At present, the company has developed into a key enterprise in the traditional Chinese medicine industry in northwest China, which integrates the cultivation and processing of traditional Chinese herbs, the research and development of natural medicines and health care products, the production and sales of modern TCM dosage forms and health food. Foci pharmaceutical has 90 years of pharmaceutical history and is the "Chinese time-honored" enterprises, founded in 1929 in Shanghai, moved to Lanzhou in 1959. In the history of Traditional Chinese Medicine development, Foci pharmaceutical has maintained the "five firsts" : the first enterprise to implement the industrial production of Traditional Chinese Medicine; The first company to produce Traditional Chinese Medicine in western method and invented Concentrated Pill; The first joint-stock company of pharmaceutical enterprise in China;The first export enterprise of Traditional Chinese Medicine; The first Traditional Chinese Medicine production enterprise pass the the GMP certification of China. The company was designated as First batch of Chinese Time-honoured Brand by the Ministry of Commerce of the People’s Republic of China, and “Foci” brand is “Famous Trademark of China”. The products of Foci are exported to 28 countries and regions. Foci is ranked among the top 10 of Traditional Chinese Medicine exporters for consecutive years. The company was listed in“the first batch of Traditional Chinese Medicine Service Trade Enterprises”by the National Ministry of Commerce and State Administration of Traditional Chinese Medicine.